US Broker Ratings

Enovis Corporation (ENOV) Stock Analysis: Uncovering a 68% Potential Upside in the Healthcare Sector

Enovis Corporation (NYSE: ENOV), a prominent player in the healthcare sector, offers a compelling opportunity for investors seeking growth in the medical devices industry. With a market capitalization of $1.77..

GeneDx Holdings Corp. (WGS) Stock Analysis: A Genomics Leader with Robust Revenue Growth

GeneDx Holdings Corp. (WGS) stands as a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Based in the United States, this genomics company is making..

Astrana Health Inc. (ASTH) Stock Analysis: A Promising 46.64% Potential Upside in the Healthcare Sector

Astrana Health Inc. (ASTH), a leading player in the medical care facilities industry, is capturing investor attention with a significant potential upside of 46.64%. With its current market cap standing..

Neogen Corporation (NEOG) Stock Analysis: Navigating Challenges with a 16% Potential Upside

Neogen Corporation (NASDAQ: NEOG), a prominent player in the Healthcare sector, specifically within the Diagnostics & Research industry, presents a complex yet intriguing case for investors. With a current market..

Mirum Pharmaceuticals, Inc. (MIRM): Investor Outlook on Biotech’s Promising 64% Revenue Growth and Analyst Consensus

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) is gaining traction in the biotechnology sector, captivating investors with its focus on rare and orphan diseases. The company’s innovative approach and promising pipeline have..

Agios Pharmaceuticals (AGIO) Stock Analysis: Exploring a Promising 27.93% Upside Potential

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is making waves in the biotechnology sector with its focus on cellular metabolism. As a biopharmaceutical company, Agios is renowned for its innovative approach to..

Structure Therapeutics Inc. (GPCR) Stock Analysis: A Biotech Gem with a 293% Upside Potential

Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company, is positioning itself as a promising contender in the biotechnology sector. With a focus on developing novel oral small molecule..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Exploring a 4.21% Potential Upside

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN), a prominent player in the healthcare sector, specifically within the medical care facilities industry, is making waves with its unique blend of technology-enabled pharmacy..

Belite Bio, Inc (BLTE) Stock Analysis: A Biotech Powerhouse with a 47% Upside Potential

Belite Bio, Inc (NASDAQ: BLTE), a pioneering force in the biotechnology sector, is capturing investor attention with its innovative approach to tackling retinal degenerative diseases. With its current market capitalization..

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: A 44% Upside Potential in the Biotech Arena

Kymera Therapeutics, Inc. (NASDAQ: KYMR) is capturing the attention of investors with its innovative approach to drug development and a significant potential upside of 44.35%. Positioned within the healthcare sector,..

Centessa Pharmaceuticals (CNTA) Stock Analysis: Exploring the 87.65% Upside Potential

Centessa Pharmaceuticals plc (NASDAQ: CNTA), a prominent player in the biotechnology sector, commands attention with its innovative clinical-stage pharmaceutical developments. With a market capitalization of $2.28 billion, this UK-based company..

Ascentage Pharma Group Internat (AAPG): Growth Potential Amidst Challenges in the Biotech Industry

Ascentage Pharma Group International (AAPG), a clinical-stage biotechnology company headquartered in Suzhou, China, is making waves in the healthcare sector with its innovative approaches to cancer and chronic disease treatments...

CONMED Corporation (CNMD) Investor Outlook: Exploring a 12.38% Potential Upside with Analyst Insights

For investors looking to delve into the healthcare sector, particularly the medical devices industry, CONMED Corporation (NASDAQ: CNMD) presents an intriguing opportunity. With a market capitalization of $1.68 billion, this..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: Exploring a 50% Potential Upside in the Biotech Sector

Scholar Rock Holding Corporation (NASDAQ: SRRK), a prominent player in the biotechnology industry, has captured investor attention with its innovative approach to treating serious diseases through the targeting of protein..

National HealthCare Corporation (NHC): Investor Outlook with a Healthy Revenue Growth of 28.7%

National HealthCare Corporation (NYSE: NHC) is a notable entity within the healthcare sector, specializing in medical care facilities across the United States. With a market capitalization of $1.74 billion, NHC..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Exploring a 162% Potential Upside in the Biotech Sector

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) is capturing the attention of investors with its significant potential upside of 162.24%, as indicated by its average target price of $37.50 against its current..

SS Innovations International (SSII) Stock Analysis: A Deep Dive into 121.80% Revenue Growth in the Healthcare Sector

SS Innovations International Inc. (NASDAQ: SSII), a promising player in the healthcare sector, is capturing attention with its impressive 121.80% revenue growth. As a commercial-stage surgical robotics company, SS Innovations..

Twist Bioscience Corporation (TWST) Stock Analysis: Unveiling a 46% Upside Potential for Investors

Twist Bioscience Corporation (NASDAQ: TWST) has captured the attention of investors with its innovative approach to synthetic DNA-based products. Operating within the healthcare sector, specifically in the diagnostics and research..

Apellis Pharmaceuticals, Inc. (APLS) Stock Analysis: A 39% Upside Potential Amidst Biotech Challenges

For investors eyeing the biotechnology sector, Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) presents a fascinating opportunity with both risks and significant upside potential. Based in Waltham, Massachusetts, this commercial-stage biopharmaceutical company..

Select Medical Holdings Corp (SEM) Stock Analysis: Exploring a 35% Potential Upside

Select Medical Holdings Corporation (NYSE: SEM) stands as a prominent player in the healthcare sector, particularly within the medical care facilities industry. Headquartered in Mechanicsburg, Pennsylvania, the company operates a..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds